BPSS1504, a cluster 1 Type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 2006-2015

  Hopf, Verena ^a   Göhler, André ^a   Eske Pogodda, Kristin ^a   Bast, Antje ^a   Steinmetz, Ivo ^a   Breitbach, Katrin ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BPRC GENE; BPSS1504 GENE; BSAN GENE; BURKHOLDERIA PSEUDOMALLEI; CELL DIVISION; CELL SURVIVAL; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GIANT CELL; HCP1 GENE; HOST CELL; MACROPHAGE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TRANSPOSON; TSSA GENE; TYPE IV SECRETION SYSTEM; VGRG GENE; VIRAG GENE; WILD TYPE;

ACTINS; ANIMALS; BACTERIAL PROTEINS; BURKHOLDERIA PSEUDOMALLEI; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MUTATION; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRULENCE; VIRULENCE FACTORS;

EID: 84898898504     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01544-14     Document Type: Article

References (44)

1. Limmathurotsakul D, Peacock SJ. 2011. Melioidosis: a clinical overview. Br. Med. Bull. 99:125-139. http://dx.doi.org/10.1093/bmb/ldr007.
2. Barnes JL, Ketheesan N. 2005. Route of infection in melioidosis. Emerg. Infect. Dis. 11:638-639. http://dx.doi.org/10.3201/eid1104.041051.
3. Peacock SJ. 2006. Melioidosis. Curr. Opin. Infect. Dis. 19:421-428. http: //dx.doi.org/10.1097/01.qco.0000244046.31135.b3.
4. Jones AL, Beveridge TJ, Woods DE. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.
5. Breitbach K, Rottner K, Klocke S, Rohde M, Jenzora A, Wehland J, Steinmetz I. 2003. Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell. Microbiol. 5:385-393. http://dx.doi.org/10.1046/j.1462-5822.2003.00277.x.
6. Stevens MP, Wood MW, Taylor LA, Monaghan P, Hawes P, Jones PW, Wallis TS, Galyov EE. 2002. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol. Microbiol. 46:649-659. http://dx.doi.org/10.1046/j.1365-2958.2002.03190.x.
7. Pilatz S, Breitbach K, Hein N, Fehlhaber B, Schulze J, Brenneke B, Eberl L, Steinmetz I. 2006. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect. Immun. 74:3576-3586. http://dx.doi.org/10.1128/IAI.01262-05.
8. Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD. 2009. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol. Rev. 33: 1079-1099. http://dx.doi.org/10.1111/j.1574-6976.2009.00189.x.
9. Galyov EE, Brett PJ, DeShazer D. 2010. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu. Rev. Microbiol. 64:495-517. http://dx.doi.org/10.1146/annurev.micro.112408.134030.
10. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, Scorpio A, Milne TS, Dean RE, Fritz DL, Peacock SJ, Prior JL, Atkins TP, Deshazer D. 2011. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect. Immun. 79: 1512-1525. http://dx.doi.org/10.1128/IAI.01218-10.
11. Shalom G, Shaw JG, Thomas MS. 2007. In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages. Microbiology 153:2689-2699. http://dx.doi.org/10.1099/mic.0.2007/006585-0.
12. Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrazek J, Nierman WC, Deshazer D. 2007. Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol. Microbiol. 64:1466-1485. http://dx.doi.org/10.1111/j.1365-2958.2007.05734.x.
13. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, Heidelberg JF, Mekalanos JJ. 2006. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc. Natl. Acad. Sci. U. S. A. 103:1528-1533. http://dx.doi.org/10.1073/pnas.0510322103.
14. Cascales E. 2008. The type VI secretion toolkit. EMBO Rep. 9:735-741. http://dx.doi.org/10.1038/embor.2008.131.
15. Filloux A, Hachani A, Bleves S. 2008. The bacterial type VI secretion machine: yet another player for protein transport across membranes. Microbiology 154:1570-1583. http://dx.doi.org/10.1099/mic.0.2008 /016840-0.
16. Hood RD, Singh P, Hsu F, Guvener T, Carl MA, Trinidad RR, Silverman JM, Ohlson BB, Hicks KG, Plemel RL, Li M, Schwarz S, Wang WY, Merz AJ, Goodlett DR, Mougous JD. 2010. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7:25-37. http://dx.doi.org/10.1016/j.chom.2009.12.007.
17. Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, Mougous JD. 2011. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475:343-347. http://dx.doi.org/10.1038/nature10244.
18. Silverman JM, Brunet YR, Cascales E, Mougous JD. 2012. Structure and regulation of the type VI secretion system. Annu. Rev. Microbiol. 66:453-472. http://dx.doi.org/10.1146/annurev-micro-121809-151619.
19. Chen Y, Wong J, Sun GW, Liu Y, Tan GY, Gan YH. 2011. Regulation of type VI secretion system during Burkholderia pseudomallei infection. Infect. Immun. 79:3064-3073. http://dx.doi.org/10.1128/IAI.05148-11.
20. Sun GW, Chen Y, Liu Y, Tan GY, Ong C, Tan P, Gan YH. 2010. Identification of a regulatory cascade controlling type III secretion system 3 gene expression in Burkholderia pseudomallei. Mol. Microbiol. 76:677-689. http://dx.doi.org/10.1111/j.1365-2958.2010.07124.x.
21. Burtnick MN, Brett PJ. 2013. Burkholderia mallei and Burkholderia pseudomallei cluster 1 type VI secretion system gene expression is negatively regulated by iron and zinc. PLoS One 8:e76767. http://dx.doi.org/10.1371 /journal.pone.0076767.
22. Lopez CM, Rholl DA, Trunck LA, Schweizer HP. 2009. Versatile dualtechnology system for markerless allele replacement in Burkholderia pseudomallei. Appl. Environ. Microbiol. 75:6496-6503. http://dx.doi.org/10.1128/AEM.01669-09.
23. Norville IH, Breitbach K, Eske-Pogodda K, Harmer NJ, Sarkar-Tyson M, Titball RW, Steinmetz I. 2011. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei. Microbiology 157:2629-2638. http://dx.doi.org/10.1099/mic.0.049163-0.
24. Choi KH, Mima T, Casart Y, Rholl D, Kumar A, Beacham IR, Schweizer HP. 2008. Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. Appl. Environ. Microbiol. 74:1064-1075. http://dx.doi.org/10.1128/AEM.02430-07.
25. Eske K, Breitbach K, Kohler J, Wongprompitak P, Steinmetz I. 2009. Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J. Immunol. Methods 342:13-19. http: //dx.doi.org/10.1016/j.jim.2008.11.011.
26. Breitbach K, Sun GW, Kohler J, Eske K, Wongprompitak P, Tan G, Liu Y, Gan YH, Steinmetz I. 2009. Caspase-1 mediates resistance in murine melioidosis. Infect. Immun. 77:1589-1595. http://dx.doi.org/10.1128/IAI.01257-08.
27. Breitbach K, Klocke S, Tschernig T, van Rooijen N, Baumann U, Steinmetz I. 2006. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect. Immun. 74:6300-6309. http://dx.doi.org/10.1128/IAI.00966-06.
28. Hegde SS, Vetting MW, Roderick SL, Mitchenall LA, Maxwell A, Takiff HE, Blanchard JS. 2005. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science 308:1480-1483. http: //dx.doi.org/10.1126/science.1110699.
29. Vetting MW, Hegde SS, Zhang Y, Blanchard JS. 2011. Pentapeptiderepeat proteins that act as topoisomerase poison resistance factors have a common dimer interface. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67:296-302. http://dx.doi.org/10.1107/S1744309110053315.
30. Tran JH, Jacoby GA. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. U. S. A. 99:5638-5642. http://dx.doi.org /10.1073/pnas.082092899.
31. Henry T, Couillault C, Rockenfeller P, Boucrot E, Dumont A, Schroeder N, Hermant A, Knodler LA, Lecine P, Steele-Mortimer O, Borg JP, Gorvel JP, Meresse S. 2006. The Salmonella effector protein PipB2 is a linker for kinesin-1. Proc. Natl. Acad. Sci. U. S. A. 103:13497-13502. http: //dx.doi.org/10.1073/pnas.0605443103.
32. Knodler LA, Steele-Mortimer O. 2005. The Salmonella effector PipB2 affects late endosome/lysosome distribution to mediate Sif extension. Mol. Biol. Cell 16:4108-4123. http://dx.doi.org/10.1091/mbc.E05-04 -0367.
33. Chieng S, Carreto L, Nathan S. 2012. Burkholderia pseudomallei transcriptional adaptation in macrophages. BMC Genomics 13:328. http://dx.doi.org/10.1186/1471-2164-13-328.
34. Burtnick MN, DeShazer D, Nair V, Gherardini FC, Brett PJ. 2010. Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect. Immun. 78:88-99. http://dx.doi.org/10.1128/IAI.00985-09.
35. Bast A, Schmidt IH, Brauner P, Brix B, Breitbach K, Steinmetz I. 2011. Defense mechanisms of hepatocytes against Burkholderia pseudomallei. Front. Microbiol. 2:277. http://dx.doi.org/10.3389/fmicb.2011.00277.
36. French CT, Toesca IJ, Wu TH, Teslaa T, Beaty SM, Wong W, Liu M, Schroder I, Chiou PY, Teitell MA, Miller JF. 2011. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc. Natl. Acad. Sci. U. S. A. 108:12095-12100. http://dx.doi.org/10.1073/pnas.1107183108.
37. Stevens JM, Ulrich RL, Taylor LA, Wood MW, Deshazer D, Stevens MP, Galyov EE. 2005. Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J. Bacteriol. 187:7857-7862. http://dx.doi.org/10.1128/JB.187.22.7857-7862.2005.
38. Sitthidet C, Korbsrisate S, Layton AN, Field TR, Stevens MP, Stevens JM. 2011. Identification of motifs of Burkholderia pseudomallei BimA required for intracellular motility, actin binding, and actin polymerization. J. Bacteriol. 193:1901-1910. http://dx.doi.org/10.1128/JB.01455-10.
39. Stevens MP, Stevens JM, Jeng RL, Taylor LA, Wood MW, Hawes P, Monaghan P, Welch MD, Galyov EE. 2005. Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Mol. Microbiol. 56:40-53. http://dx.doi.org/10.1111/j.1365-2958.2004.04528.x.
40. Pukatzki S, McAuley SB, Miyata ST. 2009. The type VI secretion system: translocation of effectors and effector-domains. Curr. Opin. Microbiol. 12:11-17. http://dx.doi.org/10.1016/j.mib.2008.11.010.
41. Phadnis SH, Das HK. 1987. Use of the plasmid pRK 2013 as a vehicle for transposition in Azotobacter vinelandii. J. Biosci. 12:131-135. http://dx.doi.org/10.1007/BF02702964.
42. Wuthiekanun V, Smith MD, Dance DA, Walsh AL, Pitt TL, White NJ. 1996. Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J. Med. Microbiol. 45:408-412. http://dx.doi.org/10.1099/00222615-45-6-408.
43. Merriman TR, Lamont IL. 1993. Construction and use of a self-cloning promoter probe vector for Gram-negative bacteria. Gene 126:17-23. http: //dx.doi.org/10.1016/0378-1119(93)90585-Q.
44. Bast A, Krause K, Schmidt I, Pudla M, Brakopp S, Hopf V, Breitbach K, Steinmetz I. Caspase-1-dependent and -independent cell death pathways in Burkholderia pseudomallei type infection of macrophages. PLoS Pathog., in press.